Clinical trial · Interventional
Multi-mode Rehabilitation of Abdominal Tumor Patients Undergoing Concurrent Chemoradiotherapy
Research on Multi-mode Rehabilitation of Abdominal Tumor Patients With Simultaneous Radiotherapy and Chemotherapy Based on Mobile Medicine.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators carry out a multi center, randomized controlled clinical study to analyze the impact of the whole process multi-mode rehabilitation management (nutrition-Sports-Psychology) on the nutritional status, physical status, psychological status, treatment side effects and the completion rate of radiotherapy and chemotherapy of patients with abdominal tumors; To explore and establish a multi-mode rehabilitation management path for patients with malignant tumors undergoing concurrent radiotherapy and chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Concurrent Chemoradiotherapy;Nutrition；Multimodal Rehabilitation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Multimodal rehabilitation | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Research Group
- description
- multi-mode rehabilitation
- interventionNames
- Behavioral: Multimodal rehabilitation
- type
- NO_INTERVENTION
- label
- control group
- description
- control group
Primary outcomes (3)
- measure
- Completion rate of concurrent chemoradiotherapy
- timeFrame
- up to 12 weeks
- description
- Completion rate of concurrent chemoradiotherapy
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients who are diagnosed as abdominal malignant tumor by pathology and / or cytology and intend to receive concurrent radiotherapy and chemotherapy; 2. Estimated survival time ≥ 3 months; 3. ECoG score 0-1; 4. The physical activity is acceptable, and the human body composition analysis and 6-minute walking test can be carried out; 5. Have reading comprehension ability and be able to complete the questionnaire. Exclusion Criteria: 1. Clinically significant cardiovascular diseases, such as heart failure (NYHA grade III-IV), uncontrolled coronary heart disease, cardiomyopathy, uncontrolled arrhythmia, uncontrolled hypertension or history of myocardial infarction in the past 1 year; 2. Neurological or psychiatric abnormalities affecting cognitive ability, including central nervous system metastasis; 3. uncontrolled systemic diseases, such as poorly controlled diabetes mellitus; 4. Allergic to milk, whey protein, etc.
References
Publications (0)
Data not yet available